Male Breast Cancer Report of a Series of 50 Cases

References

• Schottenfeld D, Lilienfeld A M, Diamond H. Some observations on the epidemiology of breast cancer among males. Am J Public Health 1963; 53: 890–7
   Web of Science ®Google Scholar
• Holleb A I, Freeman H P, Farrow J H. Cancer of the male breast. NY State Med J 1968; 68: 544–63
   Google Scholar
• Beahrs O H, Henson D E, Hutter R VP, Myers M. Manual for staging of cancer, 3rd ed. JB Lippincott, Philadelphia 1988
   Google Scholar
• Barnes D M, Ribeiro G G, Skinner L G. Two methods for the measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response to treatment. Eur J Cancer 1977; 13: 1133–43
   Web of Science ®Google Scholar
• Kozak F K, Hall J G, Baird P A. Familial breast cancer in males. A case report and review of the literature. Cancer 1986; 58: 2736–9
   PubMed Web of Science ®Google Scholar
• Anderson D E, Badzioch M D. Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 1992; 84: 1114–7
   PubMedGoogle Scholar
• Donegan W L, Perez-Mesa C M. Carcinoma of the male breast: A 30-year review of 28 cases. Arch Surg 1973; 106: 273–9
   PubMedGoogle Scholar
• Treves N, Holleb A I. Cancer of the male breast. Cancer 1955; 8: 1239–50
   PubMed Web of Science ®Google Scholar
• Vanderbilt P C, Warran S E. Forty year experience with carcinoma of the male breast. Surg Gynecol Obstet 1973; 133: 629–33
   Google Scholar
• Van Geel A N, van Slooten E A, Mavrunac M, Hart A AM. A retrospective study of male breast cancer in Holland. Br J Surg 1985; 72: 724–7
   PubMed Web of Science ®Google Scholar
• Adami H O, Holmberg L, Malker B, Ries L. Long-term survival in 406 males with breast cancer. Br J Cancer 1985; 52: 99–103
   PubMed Web of Science ®Google Scholar
• Erlichman C, Murphy K C, Elhakim T. Male breast cancer: A 13-year review of 89 patients. J Clin Oncol 1984; 2: 903–9
   PubMed Web of Science ®Google Scholar
• Henderson I C, Harris J R, Kinne D W, Hellman S. Cancer of the breast. Principles and practice of oncology, V T DeVita, S Hellman, S A Rosenberg. JB Lippincott Company, Philadelphia 1989; 1197–268, Cancer
   Google Scholar
• Crichlow R W, Spenser W G. Male breast cancer. Surg Clins N Am 1990; 70: 1165–77
   PubMed Web of Science ®Google Scholar
• Meyskens F L, Tormey D C, Neifeld J P. Male breast cancer: a review. Cancer Treat Rev 1976; 3: 83–93
   PubMed Web of Science ®Google Scholar
• Langlands A O, Maclean N, Kerr G. Carcinoma of the male breast: Report of a series of 88 cases. Clin Radiol 1976; 27: 21–5
   PubMed Web of Science ®Google Scholar
• Ouriel K, Lotze M T, Hinshaw J R. Prognostic factors of carcinoma of the male breast. Surg Gynecol Obstet 1984; 159: 373–6
   PubMedGoogle Scholar
• Ribeiro G. Male breast carcinoma. A review of 301 cases from the Christie Hospital & Holt Radium Institute. Manchester. Br J Cancer 1985; 51: 115–9
   PubMed Web of Science ®Google Scholar
• Scheike O. Male breast cancer. Six factors influencing prognosis. Br J Cancer 1974; 30: 261–71
   PubMed Web of Science ®Google Scholar
• Harris J R, Lippman M E, Veronesi U, Willett W. Breast cancer (Third of three parts). N Engl J Med 1992; 327: 473–80
   PubMed Web of Science ®Google Scholar
• Hultborn R, Friberg S, Hultborn K A, Peterson L E, Ragnhult I. Male breast carcinoma. II. A study of the total material reported to the Swedish Cancer Registry 1958–1967 with respect to treatment, prognostic factors and survival. Acta Oncol 1987; 26: 327–41
   PubMed Web of Science ®Google Scholar
• Patterson J S, Battersby L A, Bach K. Use of tamoxifen in advanced male breast cancer. Cancer Treat Rep 1980; 64: 801–4
   PubMedGoogle Scholar
• Kraybill W G, Kaufman R, Kinne D. Treatment of advanced male breast cancer. Cancer 1981; 42: 2185–9
   Google Scholar
• Bezwoda W R, Hesdorffer C, Dansey R, et al. Breast cancer in men. Clinical features, hormone receptor status, and response to therapy. Cancer 1987; 60: 1337–40
   PubMed Web of Science ®Google Scholar
• Gupta N, Cohen J L, Rosenbaum C, Raam S. Estrogen receptors in male breast cancer. Cancer 1980; 46: 1781–4
   PubMed Web of Science ®Google Scholar
• Doberauer C, Niederle N, Schmidt C G. Advanced male breast cancer treatment with the LH-RH analogue buserelin alone or in combination with the antiandrogen flutamide. Cancer 1988; 62: 474–8
   PubMed Web of Science ®Google Scholar
• Bagley C S, Wesley M N, Young R C, Lippman M E. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 1987; 10: 55–60
   PubMed Web of Science ®Google Scholar
• Patel H Z, Buzdar A U, Hortobagyi G N. Role of adjuvant chemotherapy in male breast cancer. Cancer 1989; 64: 1583–5
   PubMed Web of Science ®Google Scholar
• Ribeiro Swindell G. Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 1992; 65: 252–4
   PubMed Web of Science ®Google Scholar